S100A8 and pancreatic neoplasm: Further endpoints were to assess whether pancreatic cancer cells are able to expand MDSCs in vitro and to evaluate the role of the inhibitory co-stimulatory molecules PDL1 and CTLA4 searching also for any potential effect of the S100A8 and S100A9 molecules.